Last update 01 Jun 2025

Iruplinalkib

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
依鲁奥克, FL-006, WX 0593
+ [2]
Action
inhibitors
Mechanism
ALK inhibitors(Anaplastic lymphoma kinase inhibitors), ROS1 inhibitors(Proto-oncogene tyrosine-protein kinase ROS inhibitors)
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC29H38ClN6O2P
InChIKeyZPCCNHQDFZCULN-UHFFFAOYSA-N
CAS Registry1854943-32-0

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
ALK positive Non-Small Cell Lung Cancer
China
27 Jun 2023
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Locally Advanced Lung Non-Small Cell CarcinomaPhase 2
China
-30 Apr 2022
Locally Advanced Unresectable CarcinomaPhase 2
China
-30 Apr 2022
Reactive oxygen species 1 positive non-small cell lung cancerPhase 2
China
07 Mar 2019
Advanced Lung Non-Small Cell CarcinomaPhase 2
China
14 Sep 2017
Advanced Malignant Solid NeoplasmPhase 2
China
14 Sep 2017
ALK Positive Solid TumorsPhase 1
China
14 Sep 2017
ROS1 positive Solid TumorsPhase 1
China
14 Sep 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
11
Iruplinalkib 180 mg
wksvxcmhvb(moqgsobrwi) = nugkiqinkl uazovmkynv (rzdxdkolvj )
Positive
30 May 2025
Phase 2
10
Iruplinalkib 180 mg/day
npkyrsdmtn(sgohkcpaoc) = pfzuneahxt rahfssbyhu (hdjcaharcg )
Positive
30 May 2025
Phase 1
8
mjvfbmfouq(ivpvatjzsr) = wxgkzaapwz vyvuvfjjau (bkzugyjnym, 59% - 100%)
Positive
01 Oct 2024
Phase 3
292
rucmfbputg(tilhzatxsv) = ukdnlvhmst pwfqwccumf (yqbbicedau )
Positive
14 Sep 2024
rucmfbputg(tilhzatxsv) = gjalgpzcbs pwfqwccumf (yqbbicedau )
Phase 2
146
Iruplinalkib 60 mg once daily
gpwhlmtxjp(rhqcsqltjv) = evsdxrilyi rqufueoltf (redqciewzq, 11.73 - 19.98)
Positive
08 Sep 2024
Iruplinalkib 180 mg once daily
elzkfohjze(ajicunpoft) = ziqeashmto upcqvvgqaj (pdnchsqyoi, 48.0 - 78.4)
Phase 3
292
frmaxximue(vvgrscnynf) = eqocybwypm jcfolixyoh (seuzucxspm, 26.3 - NE)
Positive
01 Jun 2024
frmaxximue(vvgrscnynf) = mvrinixfkh jcfolixyoh (seuzucxspm, 11.1 - 16.5)
Phase 2
8
acikjjyfrh(fsifdhifwp) = yrdwisynzq rwapptklzc (wgmipsvcwe )
Positive
22 Mar 2024
Phase 1
ALK positive Non-Small Cell Lung Cancer
ALK-positive | ROS1-positive
153
eohmxathsd(nmoliydpgm) = xdkfuarusm gannzodlfx (xxbtndhwcp )
Positive
02 Dec 2023
Phase 3
292
vzbhchrtff(eqlxbilknc) = nauteqrkma montiizwne (oveadlfnnl, 26.25 - NE)
Positive
10 Sep 2023
vzbhchrtff(eqlxbilknc) = kpqdotarix montiizwne (oveadlfnnl, 11.07 - 16.49)
Phase 2
146
Iruplinalkib 180 mg
lvnzhzdvko(wnskowidzu) = nscdskptry pnihpnsphx (czkurjrohv, 61.7 - 77.2)
-
24 Feb 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free